Apple Watch Redesign Gets Early OK As Patent Loss Upheld
The Federal Circuit on Thursday affirmed a U.S. International Trade Commission decision that found a previous version of the Apple Watch infringes two Masimo blood oxygen monitor patents, but the ruling...To view the full article, register now.
Already a subscriber? Click here to view full article